CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹2,368 Cr | ₹3,481 Cr | ₹3,134 Cr | ₹2,563 Cr | ₹1,507 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹2,368 Cr |
| Mar2025 | ₹3,481 Cr |
| Mar2024 | ₹3,134 Cr |
| Mar2023 | ₹2,563 Cr |
| Mar2022 | ₹1,507 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,368 Cr | -31.99 | |
| Mar2025 | ₹3,481 Cr | 11.08 | |
| Mar2024 | ₹3,134 Cr | 22.28 | |
| Mar2023 | ₹2,563 Cr | 70.07 | |
| Mar2022 | ₹1,507 Cr | - | |
Compare Short Term Loans and Advances of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,894.2 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| MANKIND PHARMA | ₹100,364.0 Cr | 1.8% | -3.1% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 0.9% | 0% | -11% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.5% |
-3.2% |
-12.8% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses